The U.S. Food and Drug Administration recently approved aducanumab, the first treatment that aims to slow the progression of Alzheimer’s disease. But approval of the drug has provoked mixed reactions from the scientific community.
Dr. Ginevra Mills writes about the challenge: Sometimes, you and your partner have different libidos. How can you talk it out and improve the relationship?
Even though many of pharmacists’ advanced practices and areas of specialty are not yet recognized by legislators in Canada, pharmacists continue to grow their expertise to become subject matter experts in virtually all therapeutic fields.
